Phase I trial of epirubicin and taxotere [docetaxel] in patients with metastatic androgen independent prostate cancer
Phase of Trial: Phase I
Latest Information Update: 04 Dec 2008
At a glance
- Drugs Docetaxel (Primary) ; Epirubicin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2008 Status changed from suspended to completed, according to clinicaltrials.gov.
- 16 Apr 2008 The lead investigated has changed from Chaudhary UB to Kraft AS according to clinicaltrials.gov.
- 02 Jan 2008 Status changed from recruiting to suspended.